当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Lahat A and Fidder HH
Imaging studies are essential in the diagnosis, treatment and follow up of IBD patients. The use of bowel imaging serves to confirm the diagnosis, assess disease extent and characteristics (inflammatory versus fibrostenotic) and complications. Accepted methods for bowel imaging in IBD patients are: CT enterography (CTE), MR enteropgaraphy (MRE), Abdominal ultrasound and capsule endoscopy. Each technique has its advantages and disadvantages. IBD patients have relatively high risk for colorectal cancer, small bowel cancer lymphomas and other malignancies. This risk is related to the chronic inflammatory process as well as to immunosuppressive therapy. Accumulating data shows that exposure to ionizing radiation elevates the risk for malignancy. Even exposure to relatively low doses of radiation as 50 mSv was shown to cause an increase in the occurrence of solid tumors, mainly colorectal cancer and urogenital malignancies. Individualized approach considering patients' symptoms, age, medical history, previous radiation exposure and malignancy risk as well as the local facilities and experience should guide physicians' decision regarding the preferred imaging modality.